NAUTIKA1: A Multicenter Phase II Study with a PD-L1+ Cohort of Patients Receiving Atezolizumab (Atezo) with Low-Dose Stereotactic Body Radiation Therapy (SBRT) as Neoadjuvant Therapy for Resectable Stage IB-III NSCLC
Autor: | S. Tian, D.E. Kozono, N. Ohri, S. Jolly, B.E. Johnson, J. Chaft, E.M. Toloza, B. Ding, C. Ngiam, K. Schulz, I. Bara, J.M. Lee |
---|---|
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | International Journal of Radiation Oncology*Biology*Physics. 114:e392-e393 |
ISSN: | 0360-3016 |
Databáze: | OpenAIRE |
Externí odkaz: |